Development and Validation of a Contrast-Enhanced CT-Based Radiomics Nomogram for Prediction of Therapeutic Efficacy of Anti-PD-1 Antibodies in Advanced HCC Patients

BACKGROUND: There is no study accessible now assessing the prognostic aspect of radiomics for anti-PD-1 therapy for patients with HCC. AIM: The aim of this study was to develop and validate a radiomics nomogram by incorporating the pretreatment contrast-enhanced Computed tomography (CT) images and c...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Immunol
Autors principals: Yuan, Guosheng, Song, Yangda, Li, Qi, Hu, Xiaoyun, Zang, Mengya, Dai, Wencong, Cheng, Xiao, Huang, Wei, Yu, Wenxuan, Chen, Mian, Guo, Yabing, Zhang, Qifan, Chen, Jinzhang
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2021
Matèries:
Immunology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7820863/
https://ncbi.nlm.nih.gov/pubmed/33488622
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.613946
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars